Access cutting-edge progressive pulmonary fibrosis treatment through this clinical trial at a research site in Phoenix. Study-provided care at no cost to qualified participants.
Access progressive pulmonary fibrosis specialists in Phoenix at no cost
This study follows strict safety protocols and ethical guidelines
All study-related progressive pulmonary fibrosis treatment provided free
A randomized, double-blind, placebo-controlled clinical study to evaluate the safety and efficacy of 2 doses of inhaled pirfenidone (AP01) versus placebo on top of standard of care in participants with PPF over 52 weeks.
Sponsor: Avalyn Pharma Inc.
Check if you qualify for this progressive pulmonary fibrosis clinical trial in Phoenix, AZ
If you're searching for progressive pulmonary fibrosis treatment options in Phoenix, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Phoenix research site is actively enrolling participants for this clinical trial. You'll receive care from experienced progressive pulmonary fibrosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.